Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Sino Medical Sciences Technology Inc. on 6ix
Earlier from Sino Medical Sciences Technology
- Announcement on Voluntary Disclosure of the Company’s Non-Slip Element (NSE) Balloon Product Obtaining Foreign Device Registration Certification
- Announcement on Resolutions of the 7th Meeting of the 3rd Board of Supervisors
- Announcement on Voluntary Disclosure of the Non-Approval of a Subsidiary's Product Registration Application by the National Medical Products Administration
- Indicative Announcement on Changes in Shareholder's Equity
- Indicative Announcement on Result of Shareholders' Shareholding Reduction and Change in Equity Interests
Later from Sino Medical Sciences Technology
- Announcement on Voluntary Disclosure of Obtaining Registration Certificate for the Company's Coronary Stent Products Overseas
- Announcement on the Adjustment of Members of Board of Directors and Determination of Allowances for External Non-independent Directors
- Announcement on Election of Employee Director
- Announcement on U.S. Subsidiary eLum's Borrowing from a Related Party and the Related Party Transaction
- Announcement on the 2nd Vesting Result in the 3rd Vesting Period of the Initial Grant Part of the Company's 2022 Restricted Stock Incentive Plan and the Listing and Circulation of the Shares
Follow Sino Medical Sciences Technology into a list and get an email when it puts out news.
Follow Sino Medical Sciences Technology